Incruse Ellipta 62.5 MCG/INHAL Dry Powder Inhaler, 7 Blisters

RxCUI: 1596445
RxNorm name: Incruse Ellipta 62.5 MCG/INHAL Dry Powder Inhaler, 7 Blisters
Display name: Incruse Ellipta 62.5 MCG/INHAL Dry Powder Inhaler, 7 Blisters
Full name: Incruse Ellipta 62.5 MCG/INHAL Dry Powder Inhaler, 7 Blisters
Term type: SY
Status: DailyMed mapping
Updated: 2026-06-04 23:39:23

RxNav Current And Historical NDCs#

RxNav current and historical NDC rows page 1 of 1 · 0 matching rows.

No records found.

UNII Substances#

UNII substance links page 1 of 1 · 0 matching rows.

No records found.

openFDA label cross-check#

Cross-check layer: openFDA label JSON enriches search and identifies hydration gaps. The DailyMed Structured Product Label remains the canonical label presentation on FDA.report. Every label matching the complete exact-identifier union is deduplicated and paginated below.

Matched openFDA labels page 1 of 1 · 1 matching rows.

Brand, Generic, Manufacturer table
Brand	Generic	Manufacturer	SPL set ID	Effective date	Available safety fields	Join
Incruse Ellipta	UMECLIDINIUM	GlaxoSmithKline LLC	dbb64747-1505-49d7-9a33-99dd402e96d3	2023-12-13	Warnings, Adverse reactions	Exact identifier rxcui: 1596445

DailyMed RxNorm Mappings#

Set ID, RxNorm string, TTY table
Set ID	RxNorm string	TTY	SPL version	Label	Effective
dbb64747-1505-49d7-9a33-99dd402e96d3	Incruse Ellipta 62.5 MCG/INHAL Dry Powder Inhaler, 7 Blisters	SY	27	These highlights do not include all the information needed to use INCRUSE ELLIPTA safely and effectively. See full prescribing information for INCRUSE ELLIPTA. INCRUSE ELLIPTA (umeclidinium inhalation powder), for oral inhalation use Initial U.S. Approval: 2013	20231213
dbb64747-1505-49d7-9a33-99dd402e96d3	Incruse Ellipta (umeclidinium 62.5 MCG) per ACTUAT Dry Powder Inhaler, 7 ACTUAT	SY	27	These highlights do not include all the information needed to use INCRUSE ELLIPTA safely and effectively. See full prescribing information for INCRUSE ELLIPTA. INCRUSE ELLIPTA (umeclidinium inhalation powder), for oral inhalation use Initial U.S. Approval: 2013	20231213
dbb64747-1505-49d7-9a33-99dd402e96d3	Incruse Ellipta 62.5 MCG/INHAL Dry Powder Inhaler, 7 Blisters	PSN	27	These highlights do not include all the information needed to use INCRUSE ELLIPTA safely and effectively. See full prescribing information for INCRUSE ELLIPTA. INCRUSE ELLIPTA (umeclidinium inhalation powder), for oral inhalation use Initial U.S. Approval: 2013	20231213
dbb64747-1505-49d7-9a33-99dd402e96d3	7 ACTUAT umeclidinium 0.0625 MG/ACTUAT Dry Powder Inhaler [Incruse]	SBD	27	These highlights do not include all the information needed to use INCRUSE ELLIPTA safely and effectively. See full prescribing information for INCRUSE ELLIPTA. INCRUSE ELLIPTA (umeclidinium inhalation powder), for oral inhalation use Initial U.S. Approval: 2013	20231213